Laura Brege is of Mirum Pharmaceuticals, Inc.. Currently has a direct ownership of 15,703 shares of MIRM, which is worth approximately $1.12 Million. The most recent transaction as insider was on Sep 11, 2025, when has been sold 17,000 shares (Common Stock) at a price of $74.7 per share, resulting in proceeds of $1,269,900. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15.7K
0% 3M change
n/a 12M change
Total Value Held $1.12 Million

Laura Brege Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 11 2025
SELL
Open market or private sale
$1,269,900 $74.7 p/Share
17,000 Reduced 51.98%
15,703 Common Stock
Sep 11 2025
BUY
Exercise of conversion of derivative security
$255,000 $15.0 p/Share
17,000 Added 34.2%
32,703 Common Stock
May 29 2025
BUY
Exercise of conversion of derivative security
-
5,703 Added 26.64%
15,703 Common Stock

Also insider at

PCRX
Pacira BioSciences, Inc. Healthcare
ACAD
ACADIA PHARMACEUTICALS INC Healthcare
EWTX
Edgewise Therapeutics, Inc. Healthcare
LB

Laura Brege

Tampa, FL

Track Institutional and Insider Activities on MIRM

Follow Mirum Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MIRM shares.

Notify only if

Insider Trading

Get notified when an Mirum Pharmaceuticals, Inc. insider buys or sells MIRM shares.

Notify only if

News

Receive news related to Mirum Pharmaceuticals, Inc.

Track Activities on MIRM